Search research articles
Contact Us
Filters
Showing results (131-140 of 522) with videos related to
Page
of 53
Sort By:
Medicina (Kaunas, Lithuania)
|
September 27, 2025
The Gut Microbiota Axis in Social Jetlag: A Novel Framework for Metabolic Dysfunction and Chronotherapeutic Innovation
Christos Savvidis, Viviana Maggio, Manfredi Rizzo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
June 20, 2023
Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview
Ozge Telci Caklili, Mustafa Cesur, Dimitri P Mikhailidis, et al.
Journal of Diabetes Research
|
May 2, 2018
Complications of Diabetes 2017
Konstantinos Papatheodorou, Maciej Banach, Eleni Bekiari, et al.
Expert Opinion on Drug Safety
|
March 20, 2026
Cardiorenometabolic medicine as a new subspecialty in the light of novel pharmaceuticals with dual or triple benefits
Sanja Medenica, Vladimir Prelević, Nikola Zanković, et al.
PPAR Research
|
August 17, 2016
PPAR in Cardiovascular Disorders
Alexander N Orekhov, Nigora Mukhamedova, Ekaterina A Ivanova, et al.
Journal of Diabetes and Its Complications
|
August 9, 2025
The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study
Emir Muzurović, Goran Topić, Nevena Todorović, et al.
Diabetes, Obesity & Metabolism
|
December 20, 2023
Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta-analysis
Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, et al.
Medicina (Kaunas, Lithuania)
|
August 27, 2021
Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care
Ali A Rizvi, Anca Pantea Stoian, Nader Lessan, et al.
Biomedicines
|
November 27, 2021
Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
Ali A Rizvi, Anca Pantea Stoian, Andrej Janez, et al.
Acta Diabetologica
|
October 18, 2008
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
Manfredi Rizzo, Ali A Rizvi, Giovam Battista Rini, et al.
Page
of 53
Search research articles
Search
Showing results (131-140 of 522) with videos related to
Sort By:
Page
of 53
Medicina (Kaunas, Lithuania)
|
September 27, 2025
The Gut Microbiota Axis in Social Jetlag: A Novel Framework for Metabolic Dysfunction and Chronotherapeutic Innovation
Christos Savvidis, Viviana Maggio, Manfredi Rizzo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
June 20, 2023
Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview
Ozge Telci Caklili, Mustafa Cesur, Dimitri P Mikhailidis, et al.
Journal of Diabetes Research
|
May 2, 2018
Complications of Diabetes 2017
Konstantinos Papatheodorou, Maciej Banach, Eleni Bekiari, et al.
Expert Opinion on Drug Safety
|
March 20, 2026
Cardiorenometabolic medicine as a new subspecialty in the light of novel pharmaceuticals with dual or triple benefits
Sanja Medenica, Vladimir Prelević, Nikola Zanković, et al.
PPAR Research
|
August 17, 2016
PPAR in Cardiovascular Disorders
Alexander N Orekhov, Nigora Mukhamedova, Ekaterina A Ivanova, et al.
Journal of Diabetes and Its Complications
|
August 9, 2025
The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study
Emir Muzurović, Goran Topić, Nevena Todorović, et al.
Diabetes, Obesity & Metabolism
|
December 20, 2023
Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta-analysis
Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, et al.
Medicina (Kaunas, Lithuania)
|
August 27, 2021
Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care
Ali A Rizvi, Anca Pantea Stoian, Nader Lessan, et al.
Biomedicines
|
November 27, 2021
Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
Ali A Rizvi, Anca Pantea Stoian, Andrej Janez, et al.
Acta Diabetologica
|
October 18, 2008
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
Manfredi Rizzo, Ali A Rizvi, Giovam Battista Rini, et al.
Page
of 53